172 related articles for article (PubMed ID: 28190755)
1. Quantitative prediction of histamine H1 receptor occupancy by the sedative and non-sedative antagonists in the human central nervous system based on systemic exposure and preclinical data.
Kanamitsu K; Nozaki Y; Nagaya Y; Sugiyama Y; Kusuhara H
Drug Metab Pharmacokinet; 2017 Apr; 32(2):135-144. PubMed ID: 28190755
[TBL] [Abstract][Full Text] [Related]
2. Brain histamine H1 receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with 11C-doxepin.
Tashiro M; Duan X; Kato M; Miyake M; Watanuki S; Ishikawa Y; Funaki Y; Iwata R; Itoh M; Yanai K
Br J Clin Pharmacol; 2008 Jun; 65(6):811-21. PubMed ID: 18410464
[TBL] [Abstract][Full Text] [Related]
3. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
[TBL] [Abstract][Full Text] [Related]
4. Bilastine vs. hydroxyzine: occupation of brain histamine H1 -receptors evaluated by positron emission tomography in healthy volunteers.
Farré M; Pérez-Mañá C; Papaseit E; Menoyo E; Pérez M; Martin S; Bullich S; Rojas S; Herance JR; Trampal C; Labeaga L; Valiente R
Br J Clin Pharmacol; 2014 Nov; 78(5):970-80. PubMed ID: 24833043
[TBL] [Abstract][Full Text] [Related]
5. Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization.
Hishinuma S; Sato Y; Kobayashi Y; Komazaki H; Saito M
J Pharmacol Sci; 2008 May; 107(1):66-79. PubMed ID: 18446005
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Iwata R; Fujii T; Komemushi S; Ido T; Itoh M; Sasaki H; Watanabe T; Yanai K
Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
[TBL] [Abstract][Full Text] [Related]
7. Next-day residual sedative effect after nighttime administration of an over-the-counter antihistamine sleep aid, diphenhydramine, measured by positron emission tomography.
Zhang D; Tashiro M; Shibuya K; Okamura N; Funaki Y; Yoshikawa T; Kato M; Yanai K
J Clin Psychopharmacol; 2010 Dec; 30(6):694-701. PubMed ID: 21105284
[TBL] [Abstract][Full Text] [Related]
8. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography.
Yanai K; Ryu JH; Watanabe T; Iwata R; Ido T; Sawai Y; Ito K; Itoh M
Br J Pharmacol; 1995 Sep; 116(1):1649-55. PubMed ID: 8564232
[TBL] [Abstract][Full Text] [Related]
9. Cell-based, animal and H
Feng F; Fawcett JP; Zhang H; Tucker IG
J Pharm Pharmacol; 2020 Apr; 72(4):507-518. PubMed ID: 32030755
[TBL] [Abstract][Full Text] [Related]
10. CNS effects of the antihistamines diphenhydramine and terfenadine (RMI 9918).
Fink M; Irwin P
Pharmakopsychiatr Neuropsychopharmakol; 1979 Jan; 12(1):35-44. PubMed ID: 33398
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography evaluation of sedative properties of antihistamines.
Yanai K; Zhang D; Tashiro M; Yoshikawa T; Naganuma F; Harada R; Nakamura T; Shibuya K; Okamura N
Expert Opin Drug Saf; 2011 Jul; 10(4):613-22. PubMed ID: 21521134
[TBL] [Abstract][Full Text] [Related]
12. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
13. Dissociation between central and peripheral antihistamine activities of the new antiallergic agent N-[4-[4-(diphenylmethyl)-1-piperazinyl]-butyl]-3-(6-methyl-3-pyridyl) acrylamide in rats and monkeys.
Ishii K; Yakuo I; Nakagawa H; Nakamura H
Arzneimittelforschung; 1993 Jun; 43(6):668-71. PubMed ID: 8102529
[TBL] [Abstract][Full Text] [Related]
14. Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers.
Sato H; Ito C; Hiraoka K; Tashiro M; Shibuya K; Funaki Y; Yoshikawa T; Iwata R; Matsuoka H; Yanai K
Psychopharmacology (Berl); 2015 Oct; 232(19):3497-505. PubMed ID: 26146015
[TBL] [Abstract][Full Text] [Related]
15. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
[TBL] [Abstract][Full Text] [Related]
16. Brain histamine H1 receptor occupancy of loratadine measured by positron emission topography: comparison of H1 receptor occupancy and proportional impairment ratio.
Kubo N; Senda M; Ohsumi Y; Sakamoto S; Matsumoto K; Tashiro M; Okamura N; Yanai K
Hum Psychopharmacol; 2011 Mar; 26(2):133-9. PubMed ID: 21433074
[TBL] [Abstract][Full Text] [Related]
17. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
18. First and second generation H₁ histamine receptor antagonists produce different sleep-inducing profiles in rats.
Unno K; Ozaki T; Mohammad S; Tsuno S; Ikeda-Sagara M; Honda K; Ikeda M
Eur J Pharmacol; 2012 May; 683(1-3):179-85. PubMed ID: 22449385
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
20. Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments.
Kanamitsu K; Arakawa R; Sugiyama Y; Suhara T; Kusuhara H
Drug Metab Pharmacokinet; 2016 Dec; 31(6):395-404. PubMed ID: 27745731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
